Overview of mass spectrometry-based metabolomics: opportunities and challenges.

  title={Overview of mass spectrometry-based metabolomics: opportunities and challenges.},
  author={G. Gowda and D. Djukovic},
  journal={Methods in molecular biology},
  • G. Gowda, D. Djukovic
  • Published 2014
  • Computer Science, Medicine
  • Methods in molecular biology
  • The field of metabolomics has witnessed an exponential growth in the last decade driven by important applications spanning a wide range of areas in the basic and life sciences and beyond. Mass spectrometry in combination with chromatography and nuclear magnetic resonance are the two major analytical avenues for the analysis of metabolic species in complex biological mixtures. Owing to its inherent significantly higher sensitivity and fast data acquisition, MS plays an increasingly dominant role… CONTINUE READING
    129 Citations

    Topics from this paper

    Overview of NMR Spectroscopy-Based Metabolomics: Opportunities and Challenges.
    • 3
    Review of recent developments in GC–MS approaches to metabolomics-based research
    • 51
    Technical Challenges in Mass Spectrometry-Based Metabolomics.
    • F. Matsuda
    • Computer Science, Medicine
    • Mass spectrometry
    • 2016
    • 22
    • PDF
    MS2 and LC libraries for untargeted metabolomics: Enhancing method development and identification confidence.
    • 1


    Mass spectrometry: from proteomics to metabolomics and lipidomics.
    • W. Griffiths, Yuqin Wang
    • Chemistry, Medicine
    • Chemical Society reviews
    • 2009
    • 217
    • PDF
    Metabolomics and cardiovascular biomarker discovery.
    • 171
    • PDF
    Biomarker Discovery and Translation in Metabolomics.
    • 50
    A practical guide to metabolomic profiling as a discovery tool for human heart disease.
    • 71
    • PDF
    Metabolomics in the study of kidney diseases
    • 195
    Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
    • 18
    Recent advances in metabolomics in oncology.
    • 48
    Metabolomics in toxicology: preclinical and clinical applications.
    • 162
    • PDF